Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Oct 20, 2022

SELL
$96.76 - $112.03 $32,801 - $37,978
-339 Reduced 1.95%
17,090 $1.68 Million
Q2 2022

Jul 08, 2022

SELL
$102.07 - $123.37 $550,463 - $665,334
-5,393 Reduced 23.63%
17,429 $1.91 Million
Q1 2022

Apr 12, 2022

BUY
$114.02 - $139.04 $226,785 - $276,550
1,989 Added 9.55%
22,822 $2.74 Million
Q4 2021

Jan 12, 2022

BUY
$115.53 - $141.46 $474,135 - $580,551
4,104 Added 24.53%
20,833 $2.83 Million
Q3 2021

Oct 12, 2021

SELL
$116.66 - $129.06 $83,995 - $92,923
-720 Reduced 4.13%
16,729 $1.98 Million
Q2 2021

Jul 09, 2021

SELL
$105.79 - $124.53 $120,389 - $141,715
-1,138 Reduced 6.12%
17,449 $2.08 Million
Q1 2021

Apr 14, 2021

BUY
$108.84 - $128.23 $82,391 - $97,070
757 Added 4.25%
18,587 $2.29 Million
Q4 2020

Jan 13, 2021

BUY
$105.0 - $114.42 $1.87 Million - $2.04 Million
17,830 New
17,830 $1.98 Million
Q4 2020

Jan 12, 2021

SELL
$105.0 - $114.42 $2.4 Million - $2.61 Million
-22,841 Closed
0 $0
Q3 2020

Oct 13, 2020

BUY
$91.64 - $111.29 $2.09 Million - $2.54 Million
22,841 New
22,841 $2.54 Million
Q4 2017

Feb 09, 2018

SELL
$53.68 - $57.47 $54,699 - $58,561
-1,019 Closed
0 $0
Q2 2017

Aug 16, 2017

BUY
N/A
1,019
1,019 $50,000

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $207B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Mcia Inc Portfolio

Follow Mcia Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mcia Inc, based on Form 13F filings with the SEC.

News

Stay updated on Mcia Inc with notifications on news.